Back

Emerging role of inflammatory pathways on coronary atherosclerotic risk in patients with chronic coronary syndromes under current treatment

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipid-lowering and inflammation Inflammation and Immunity ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Chiara Caselli

CNR – National Research Council, Pisa (Italy)

7 More presentations in this session

Presentation thumbnail
Association of colchicine with cardiovascular outcomes in patients with acute coronary syndrome
Doctor M. Tao (Hartford, US)
Abstract Slides Video
Presentation thumbnail
Non-steroidal anti-inflammatory drug use after invasive and non-invasive diagnostic procedures for coronary artery disease by the degree of disease: a Danish drug utilization study (2008-2021)
Doctor A. Bech-Drewes (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Healed plaque and systemic thrombogenicity in patients with chronic coronary syndrome
Doctor D. Kinoshita (Yamagata, JP)
Abstract Slides Video
Presentation thumbnail
Effects of vitamin k2 and d3 supplementation on cardiac and systemic inflammation: a randomized controlled trial
Doctor S. Hasific (Odense, DK)
Abstract Slides Video
Presentation thumbnail
The impact of very highly elevated lipoprotein(a) levels on the early onset, complexity, and extent of coronary artery disease
Mr C. Coerkamp (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Lipid-lowering and inflammation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Resistin and CRP as strong predictors of coronary multivessel disease in acute coronary syndrome
thumbnail
Congress Presentation
Coronary inflammation stratifies risk in patients undergoing coronary CT angiography: the Oxford Risk Factors and Non-Invasive Imaging (ORFAN) study
thumbnail
Congress Presentation
Cardiovascular and inflammatory biomarkers for non-invasive detection of coronary artery obstruction and prediction of long-term survival in patients with suspected chronic coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources